Tumor Secretion of CCL22 Activates Intratumoral Treg Infiltration and Is Independent Prognostic Predictor of Breast Cancer

• Ya-Qing Li ,

  Contributed equally to this work with: Ya-Qing Li, Fang-Fang Liu

  Affiliations Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

  ⨯
• Fang-Fang Liu ,

  Contributed equally to this work with: Ya-Qing Li, Fang-Fang Liu

  Affiliations Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

  ⨯
• Xin-Min Zhang,

  Affiliation Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, Pennsylvania, United States of America

  ⨯
• Xiao-Jing Guo,

  Affiliations Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

  ⨯
• Mei-Jing Ren,

  Affiliations Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

  ⨯
• Li Fu

  * E-mail: fuli@tijmu.edu.cn

  Affiliations Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin, China

  ⨯